Red de Trastornos Adictivos - [EVENTO] Reunión Científica de la Red de Trastornos Adictivos 2009
Inicio
[EVENTO] Reunión Científica de la Red de Trastornos Adictivos 2009 PDF Imprimir E-Mail

Reunión Científica 2009 Los próximos 15 y 16 de septiembre de 2009 tendrá lugar la Reunión Científica de la Red de Trastornos Adictivos, que se realizará en el Palacio de Congresos de Tarragona como actividad complementaria del XIII Congreso de la Sociedad Española de Neurociencia.

 

Descarga de cartel (PDF)

Descarga del Programa Científico (PDF)

Descarga del Libro de Resúmenes (PDF)

 

 

 

 

PROGRAMA

Descarga del Programa Científico (PDF)

LIBRO DE RESUMENES

Descarga del Libro de Resúmenes (PDF)

 

ENVIO DE RESUMENES

El plazo para la remisión del abstract se cierra el 20 de Mayo de 2009. El comité científico de la RTA, formado por los coordinadores de las diferentes áreas decidirá que comunicaciones serán orales y cuales irán en formato póster. Los abstracts y los pósteres deberán escribirse en ingles y se editará un volumen con su contenido.

Puede descargar el documento ejemplo del congreso (DOC).

 

PROGRAMA

 

El formato de la reunión será mixto, con comunicaciones orales de 10 minutos y pósteres. El horario será el siguiente:

MARTES 15

15:00 a 15:30 - COLOCACION DE POSTERES      

15:30 a 17:30 - SESION 1


Alcohol:  neurofarmacología y terapeúticaexperimental

1. CANNABINOID RECEPTOR ACTIVATION AND ALCOHOL SELF-ADMINISTRATION DURING RELAPSE CORRELATES WITH A REDUCTION OF ADULT HIPPOCAMPAL NEUROGENESIS. J.A. Lopez Moreno. Department of Psychobiology, Faculty of Psychology, Campus de Somosaguas, Complutense University of Madrid, 28223 Madrid

2. ROLE OF INTRACELLULAR CALCIUM IN ETHANOL SELF-ADMINISTRATION AND LOCOMOTOR STIMULATION.P. Baliño.  Area de Psicobiología, Universitat Jaume I, Avda. Sos Baynat s/n, 12071, Castellón

3. CENTRAL MELANOCORITNS MODULATE VOLUNTARY ETHANOL CONSUMPTION.I Cubero. Departamento de Neurociencia y CC de la Salud, Universidad de Almería

4. DELETION OF THE PROPYNORPHIN GENE INCREASED VULNERABILITY TO ETHANOL CONSUMPTION ASSOCIATED TO CHANGES IN TYROSINE HYDROXILASE, PROENKEPHALIN AND DOPAMINE TRANPORTER GENE EXPRESSIONS AND OPIOID RECEPTORS FUNCTIONAL ACTIVITIES.T. Femenia. Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-CSIC, Apartado de correos 18, 03550 San Juan de Alicante

5. EBSELEN, AN ANTIOXIDANT WITH RADICAL SCAVENGING ACTIVITY FOR H2O2 REDUCES ETHANOL-STIMULATED BEHAVIOR IN MICE. J.C. Ledesma. Dep. de Psicologia Bàsica, Clínica i Psicobiologia – Psicobiología. Universidad Jaime I. Castellon

6. INTERMITTENT ALCOHOL EXPOSURE DURING ADOLESCENCE PROMOTES ALCOHOL INTAKE AND ACTIVATES THE MESOLIMBIC DOPAMINERGIC SYSTEM-M. Pascual. Centro de Investigación Príncipe Felipe, Avda. Autopista del Saler 16, Valencia

7.       ETHANOL IMPAIRS EXTRACELLULAR ZINC INTAKE IN CULTURED ASTROCYTES. X: Ponsoda. Dep. Cell Biol.,Univ. of Valencia

8. PRE-EXPOSURE TO ETHANOL AND MDMA DURING ADOLESCENCE INCREASES THE CONDITIONED REWARDING EFFECTS OF MDMA AND DRUG-INDUCED REINSTATEMENT. B Ribeiro do COuto. Unidad de Investigación Psicobiología de las Drogodependencias, Departamento de Psicobiologia, Universidad de Valencia


 

17:30 a 18:00 - CAFÉ


18:00 a 20:00 - SESION 2                                         

Cocaína:  estudios básicos y clínicos

1. OPPOSITE REGULATION OF FAS-ASSOCIATED PROTEIN WITH DEATH DOMAIN (FADD) AND NUCLEAR ENZYME POLY(ADP-RIBOSE) POLYMERASE (PARP) IN BRAINS OF COCAINE ADDICTS M Alvaro Bartolome. Laboratorio de Neurofarmacología-IUNICS, Universitat de les Illes Balears

2. EFFECTS OF OLEOYLETHANOLAMIDE ON COCAINE-INDUCED BEHAVIOURAL SENSITIZATION AND CONDITIONED PLACE PREFERENCE MEDIATED BY PPARα RECEPTOR. E. Blanco-Calvo. Laboratorio de Medicina Regenerativa, Fundación IMABIS, Hospital Regional Universitario Carlos Haya,  29010 Málaga.

3. LA SENSIBILIZACIÓN MOTORA A DROGAS DE ABUSO COMO FACTOR DE  VULNERABILIDAD A LA ADICCIÓN: MODULACIÓN POR SP. E. del Rio. Instituto de Neurociencias, Universidad Miguel Hernandez-CSIC. Apartado Correos 18, 03550 Sant Joan d´Alacant. Alicante

4. TWO TYPE OF MOLECULES INVOLVED IN SENSITIZATION TO DRUGS OF ABUSE: D-SERINE WITHIN THE VENTRAL TEGMENTAL AREA, AND NUCLEAR PPAR-a RECEPTORS E.F. Espejo. Departamento de Fisiología Médica, Universidad de Sevilla, 41009 Sevilla.

5. EXPERIMENTAL EVIDENCE SUPPORTING N-SUBSTITUTED BENZTROPINE ANALOGS AS CANDIDATES FOR REPLACEMENT MEDICATION IN COCAINE ADDICTION A. Ferragud. Biopsychology and Comparative Neuroscience Group, Cavanilles Institute (ICBiBE), University of Valencia-General Foundation

6. COCAINE-INDUCED REINSTATEMENT DIFFERENCES IN DRUG-SEEKING BEHAVIOUR AND ACCUMBAL GLUTAMATE OR GABA RESPONSE IN LEWIS AND FISCHER 344 RATS M. Miguens. Departamento de Psicobiología. Facultad de Psicología. UNED. C/Juan del Rosal nº10. 28040 Madrid

7. COCAINE INCREASES MDMA-INDUCED STRIATAL FREE RADICAL FORMATION IN MICE BUT FAILS TO POTENTIATE MDMA-INDUCED DOPAMINERGIC TOXICITY: A ROLE FOR GLUTATHIONE PEROXIDASE?. I Peraile. Dept. Farmacología, Facultad Medicina, Universidad Complutense, Madrid

8. TOPIRAMATO AMELIORATES COCAINE-INDUCED CENTRAL NERVOUS SYSTEM BIOCHEMICAL AND FUNCTIONAL IMPAIRMENTS. J.Romero  Universidad Cardenal Herrera-CEU

9. SIMULTANEOUS EXPOSURE OF RATS TO IMMOBILIZATION STRESS AND AMPHETAMINE ADMINISTRATION REVEALS ACTIVATION OF THE SAME NEURONAL POPULATIONS IN A WIDE RANGE OF BRAIN AREAS D. Rotllant. Institute of Neurosciencies and Animal Physiology Unit (School of Biosciences), Autonomous University of Barcelona, 08193, Bellaterra, Barcelona

10. N-SUBSTITUTED BENZTROPINE ANALOGS EFFECTIVELY ANTABONIZED THE EARY-GENE ACTIVATION AND BEHAVIORAL EFFECTS INDUCED BY COCAINE AND AMPHETAMINE ADMINISTRATION. C. Velazquez-Sanchez. Biopsychology and Comparative Neuroscience Group, Cavanilles Institute (ICBiBE), University of Valencia-General Foundation

 

MIERCOLES 16

09:00 a 11:15 - SESION 3                                          

Cannabinoides: farmacologia y papel en la adicción

1. BIS-PYRAZOLE-3-CARBOXAMIDES AS BIVALENT CANNABINOID LIGANDS: SYNTHESIS AND PHARMACOLOGICAL EVALUATION C Fernandez-Fernandez. Instituto de Química Médica, CSIC, Juan de la Cierva 3, 28006, Madrid

2. INVOLVEMENT OF 2-AG SIGNALLING IN THE ELEVATED CONSUMPTION OF AN PREFERENCE FOR ETHANOL OBSERVED IN MICE INJECTED WITH NEUROTOXIC METH N Llopis Dept. Farmacologia, Fac. Medicina, Universidad Complutense, Madrid

3. EFFECTS OF THE ADMINISTRATION OF CANNABINOID MODULATORS ON COCAINE-INDUCED MOTOR CONDITIONING/BEHAVIOURAL SENSITIZATION AND STEREOTYPED BEHAVIOUR IN MICE M Luque-Rojas. Laboratorio de Medicina Regenerativa, Fundación IMABIS, Hospital Regional Universitario Carlos Haya, Avenida Carlos Haya 82, 29010 Málaga

4. TWO ENDOCANNABINOIDS GENERATED BY SEPARATE SIGNALS MEDIATE DISTINCT FORMS OF SYNAPTIC PLASTICITY IN A SINGLE NEURON. P Grandes. Department of Neurosciences, Faculty of Medicine and Dentistry, University of The Basque Country, E-48940, Leioa, Vizcaya

5. CANNABINOID MODULATION OF HIPPOCAMPAL LONG-TERM MEMORY IS MEDIATED BY mTOR SIGNALING E. Puighermanal. Laboratori de Neurofarmacologia. Facultat de Ciències de la Salut i de la Vida. Universitat Pompeu Fabra. Barcelona

6. SEX DIFFERENCES AFFECTING THE ENDOCANNABINOID SYSTEM AND ITS INTERACTIONS WITH EARLY LIFE STRESS AND OTHER DRUGS OF ABUSE MP Viveros.  Departamento de Fisiología (Fisiología Animal II), Facultad de Biología, Universidad Complutense, Ciudad Universitaria, 28040 Madrid

7. EFFECTS OF REPEATED WITHDRAWALS ON THE EXPRESSION OF ENDOCANNABINOID SYSTEM IN THE BRAIN P Rivera. Laboratorio de Medicina Regenerativa, IMABIS, Hospital Carlos Haya, Málaga

Otros aspectos de la adicción

1. NEW INSIGHTS INTO BRAIN GLUTAMINASES: BEYOND THEIR ROLE ON GLUTAMATERGIC TRANSMISSION. C. Cardona. Dept. Molecular Biology and Biochemistry. University of Malaga. Malaga 29071

2. ROLE OF THE ENDOCANNABINOID SYSTEM IN LIPIDIC AND GLUCIDIC METABOLISM OF THE SKELETAL MUSCLE. A. Crespillo. Laboratorio de Medicina Regenerativa, IMABIS, Hospital Carlos Haya, Málaga

3. LONG-TERM SPATIAL AND WORKING MEMORY DEFICITS IN AN ADOLESCENT RAT MODEL OF BINGRE POLYDRUG USE. V. Hernández-Rabasa. Biopsychology and Comparative Neuroscience Group, Cavanilles Institute (ICBiBE), University of Valencia-General Foundation

4. ROAD RAGE AND DRUG CONSUMPTION. FJ Alvarez. Institute for Alcohol and Drug Studies, Faculty of Medicine, Pharmacology and Therapeutics, University of Valladolid, 47005 Valladolid

11:15 a 12:00 - CAFÉ

12:00 a 13:30 - SESION 4                                          

Neurofarmacología del MDMA (Extasis)

1. EFFECT OF MDMA ON CYTOSOLIC CALCIUM LEVELS IN PC12 CELLS. ROLE OF NICOTINIC RECEPTORS. D. Pubill. Unidad de Farmacología y Farmacognosia. Facultad de Farmacia. Instituto de Biomedicina de la U.B. (IBUB). Av. Joan XXIII s/n. 08028 Barcelona

2. SELECTIVE VULNERABILITY OF DOPAMINERGIC TERMINALS IN STRIOSOMES AFTER MDMA AND METH ADMINISTRATION N Granado. Instituto Cajal, CSIC, 28002 Madrid, Spain, CIBERNED, Inst. de Salud Carlos III 28002 Madrid

3. CHANGES IN COGNITIVE AND EMOTIONAL PROCESSES AFTER ADMINISTRATION OF A NEUROTOXIC DOSE OF MDMA TO DARK-AGOUTI RATS A Higuera-Matas. Dpto. Farmacología, Facultad Medicina, Universidad Complutense, Madrid

4. PRETREATMENT WITH LOW DOSE MDMA PRODUCES LONG-LASTING PROTECTION AND REDUCES MICROGLIAL ACTIVATION BY NEUROTOXIC MDMA WITHOUT PRODUCING CHANGES IN THE 5-HT TRANSPORTER A Mayado Dept. Farmacología, Facultad Medicina, Universidad Complutense, Madrid

5. INVOLVEMENT OF A2A ADENOSINE RECEPTORS ON THE REINFORCING EFFICACY OF MDMA AND NEUROTOXICITY J Ruiz-Medina. Grup de Recerca de Neurobiología del Comportament. PRBB. Universitat Pompeu Fabra

6. THE CB2 AGONIST JWH-015 REDUCES THE NEUROINFLAMMATORY RESPONSE INDUCED BY NEUROTOXIC MDMA E. Torres. Dept Farmacología, Facultad Medicina, Universidad Complutense, Madrid

7. PIOGLITAZONE DOES NOT PROTECT AGAINST MDMA-INDUCED LOSS OF 5-HT NERVE TERMINALS IN RAT BRAIN A Urrutia. Dept. Farmacología, Facultad Medicina, Universidad Complutense, Madrid

13:30 a 14:00 - INFORME DEL COORDINADOR

14:00 a 15:15 - COMIDA                                          

15:15 a 16:30 - SESION 5                                          

Opiáceos

1. ASSOCIATION OF MYOCD, GRM6 AND CRY GENES WITH RESPONSE TO METHANODE MAINTENANCE TREATMENT F. Fonseca. Drug Addiction Unit, IAPS-Hospital del Mar, Barcelona

2. BRAIN STRESS SYSTEM RESPONSES TO MORPHINE DEPENDENCE AND WITHDRAWAL C Nuñez. Departamento de Farmacología, GI Farmacología Celular y Molecular, Universidad de Murcia. Campus de Espinardo, 30100 Murcia

3. FENTANYL AN SNC-80 UPREGULATE P25, AN ACTIVATOR OF CYCLIN-DEPENDENT KINASE 5 (CDK5), IN RAT BRAIN: FUNCTIONAL INTERACTION WITH THE MEK-ERK PATHWAY A. Ramos-Miguel.  Laboratorio de Neurofarmacologia-IUNICS, Universitat de les Illes Balears, Palma de Mallorca

4. PSYCHIATRIC MORBIDITY AMONG COCAINE AND HEROIN USERS S Tortajada.  CIBER en Epidemiología y Salud Pública (CIBERESP)

5. THE TRANSFORMING GROWTH FACTOR-b FAMILY OF CYTOKINES IS INVOLVED IN OPIOID PHYSICAL DEPENDENCE  M Tramullas. Instituto de Formación e Investigación Marqués de Valdecilla, Santander

 CIERRE DE LA JORNADA CIENTIFICA

 
< Anterior
 
Advertisement

Encuestas

¿Considera que la Adicción es una Enfermedad?